ZNF280D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.715700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.539600E-01
Normal-vs-Stage2
2.255600E-02
Normal-vs-Stage3
7.858500E-03
Normal-vs-Stage4
1.883570E-01
Stage1-vs-Stage2
2.235900E-02
Stage1-vs-Stage3
6.502400E-03
Stage1-vs-Stage4
2.355400E-01
Stage2-vs-Stage3
1.082780E-01
Stage2-vs-Stage4
7.663200E-01
Stage3-vs-Stage4
1.628250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.988000E-02
Normal-vs-AfricanAmerican
1.321980E-01
Normal-vs-Asian
6.069900E-02
Caucasian-vs-AfricanAmerican
9.746400E-01
Caucasian-vs-Asian
3.459400E-01
AfricanAmerican-vs-Asian
6.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.464400E-02
Normal-vs-Female
3.892300E-02
Male-vs-Female
6.524800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.861560E-01
Normal-vs-Age(41-60Yrs)
1.187890E-02
Normal-vs-Age(61-80Yrs)
4.139600E-02
Normal-vs-Age(81-100Yrs)
8.796100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.892200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.318800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.192200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.895000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.462600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.576000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.266000E-02
Normal-vs-Daily Drinker
4.957600E-02
Normal-vs-Weekly Drinker
2.555600E-02
Normal-vs-Occasional Drinker
3.349500E-02
Normal-vs-Social Drinker
1.274850E-01
Non Drinker-vs-Daily Drinker
7.323400E-01
Non Drinker-vs-Weekly Drinker
3.608800E-01
Non Drinker-vs-Occasional Drinker
8.992000E-01
Non Drinker-vs-Social Drinker
8.815000E-01
Daily Drinker-vs-Weekly Drinker
5.708000E-01
Daily Drinker-vs-Occasional Drinker
6.581800E-01
Daily Drinker-vs-Social Drinker
6.868000E-01
Weekly Drinker-vs-Occasional Drinker
3.023800E-01
Weekly Drinker-vs-Social Drinker
3.950200E-01
Occasional Drinker-vs-Social Drinker
9.663200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.555600E-02
Normal-vs-Grade 2
2.738800E-03
Normal-vs-Grade 3
2.818000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.434200E-01
Grade 1-vs-Grade 3
7.747200E-01
Grade 1-vs-Grade 4
3.555600E-02
Grade 2-vs-Grade 3
9.869800E-01
Grade 2-vs-Grade 4
2.738800E-03
Grade 3-vs-Grade 4
2.818000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.455000E-03
Normal-vs-NonDiabetic
3.851500E-02
Diabetic-vs-NonDiabetic
1.344950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.194400E-02
Normal-vs-NoPancreatitis
2.235700E-02
Pancreatitis-vs-NoPancreatitis
7.668400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.771700E-02
Normal-vs-N1
3.360300E-02
N0-vs-N1
6.600800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.942400E-02
Normal-vs-TP53-NonMutant
2.241600E-01
TP53-Mutant-vs-TP53-NonMutant
2.799200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
